Stop losing patients after a few visits.

A subscription means you only pay if you're getting value. The hardware is a means to an end. What you're really paying for is the software, the reports, the ongoing support, and updates that keep making it better. Your first 30 days are free starting when your device is delivered, with no return required if it's not for you. After that it's $0 down and $150/mo, month-to-month, cancel anytime. Low barrier to try, easy to walk away if it stops working for your practice.

It depends on a lot of variables specific to your practice. We aim to recover a proportion of what's lost to perception-based dropout. See how much your practice is losing to dropout.

Card on file at signup, but no charge until 30 days after your device is delivered. The trial clock starts when MuscleMapper lands at your door, not when you sign up, so you get a real 30 days with the device in hand. The MuscleMapper ships free. If it's not for you, keep the device with no return needed. You'll get a reminder email a week and a day before the first charge so nothing sneaks up on you. After the trial, the standard $150/mo kicks in, month-to-month, cancel anytime from your dashboard. One note: the 14-day money-back guarantee offered on the standard plan does not apply to trial users. The 30-day trial is your try-it-free window.

The day your MuscleMapper is marked Delivered by the carrier. If shipping takes 3 days, your 30-day trial begins on day 3, and your first charge is on day 33. We track delivery via the shipping carrier's confirmation, so the start date is whatever day the package actually arrives.

Yes. MuscleMapper uses myotonometry, a quantitative method for measuring soft tissue stiffness that's been in the peer-reviewed literature since the late 1990s. Specifically the force-displacement approach (ΔF/ΔL), same method category as the original Neurogenic Technologies Myotonometer. Published studies show stiffness tracks with laterality of pain (Wu et al., PMC8866935), is elevated in chronic pain as a signal independent from pain itself (Lederer et al., PMC6942862), and reflects treatment response across a course of care (McGowen et al., J Athletic Training 2023, PMC11215642). A 2024 systematic review of 48 studies found good-to-excellent reliability for stiffness (ICCs 0.75-0.91, PMC11205912). Honest framing: well-established method, newer hardware. MuscleMapper as a specific device has not been independently published yet. For the full writeup with hardware specs, read the research breakdown or email harrisonshu@getmusclemap.com.

Log into your account at app.getmusclemap.com/dashboard and click "Manage your subscription." One click. No phone call, no email, no return required. During the 30-day post-delivery trial there's no charge to cancel. After the trial, it's month-to-month. Cancel anytime.

No. INSiGHT measures sEMG (nerve function). MuscleMap measures soft tissue stiffness via force-displacement. Different tool, different data. $0 down, $150/mo vs $17,700 upfront. No subluxation claims.

Not absolute values. But same patient, same time, same protocol = meaningful comparison across visits. Patterns are what matter, guarding, asymmetry, treatment response. We track relative change, not absolute diagnosis.

Free for 30 days starting when your device arrives, then $0 down and $150/mo, month-to-month, cancel anytime. If the trial doesn't work out, there's no need to return the device. We'll remind you a week and a day before the billing date so nothing sneaks up on you.

Good. If they're actually better, they should stop. The data is honest. Patients who see honest data trust you more. They come back when they need to, and they refer.